More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.

Treating chronic kidney disease first requires identifying the underlying cause, then trying to slow the progression while also reducing complications that may affect other organs, like the heart.

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

10 effective empty stomach drinks that can help manage kidney health, reduce damage, and improve renal function without the ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, developed by pharmaceutical company Novo Nordisk (NYSE:NVO). The medication is ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.